Sector
Health Care
Industry
Drug Manufacturers - Specialty & Generic
Ticker
688176
Website
asieris.cnFounded
2010
About Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)
Jiangsu Yahong Meditech Co., Ltd., a pharmaceutical company, focuses on urogenital tumors and women's health in China and internationally. Its pipeline includes APL-1202, which is in Phase III clinical trial for the treatment of urinary system tumors; APL-1501, an oral MetAP inhibitor that is in Phase I clinical trial for the treatment of urinary system tumors; APL-1706, which is in Phase III clinical trial for the treatment of urinary system tumors; and APL-1702, a photodynamic therapy product that is in Phase III clinical trial for the treatment of cervical high-grade squamous intraepithelial lesions of the cervix. In addition, it develops targeted protein degraders which are in preclinical stage comprising ASN-240 and ASN-2304 for the treatment of urinary system tumors; and APL-1901 for the treatment of ER positive breast cancer. Further, the company develops APL-2302 which is in phase I of clinical trial for the treatment of ovarian cancer, breast cancer, etc.; and APL-2501, AT-018, and AT-021 which are in the preclinical research phase for the treatment of Ovarian cancer, breast cancer, and other solid tumors. Additionally, the company develops APL-1401 to treat moderately to severely active ulcerative colitis, ASN-1202 to treat free-living amebic infection, and APL-2301 for the treatment of Acinetobacter baumannii Infections. The company also offers TIMIN platform, a targeted immune regulation normalization technology platform for the development of new drugs for tumor immunotherapy and autoimmune diseases, TAIDD, a drug discovery platform that integrates physical modeling and artificial intelligence technologies, including core functional modules for target-based drug discovery, and DDC, a drug-device combination platform to deliver diagnostic or therapeutic drugs for the target site to reduce the systemic exposure of the drug. Jiangsu Yahong Meditech Co., Ltd. was founded in 2010 and is based in Shanghai, China.
Integration
Every way to get the Jiangsu Yahong Meditech Co., Ltd. (SHA:688176) logo
Same endpoint, same logo, resolved from whichever identifier your data already has. Pick one below to see the exact call -- SVG, PNG and WebP all come back from the same CDN-backed URL.
View full API docs<img src="https://api.logostream.dev/stocks/isin/CNE100005XW0?key=YOUR_API_KEY&variant=logo"
alt="Jiangsu Yahong Meditech Co., Ltd. (SHA:688176) logo"
width="64" height="64" /><a href="https://logostream.dev">Logos provided by logostream</a>Why Use Our Stock Logo API?
Fast Delivery
<100ms response time via global CDN
Enterprise-Ready
99.99% uptime SLA with GDPR compliance
Multiple Formats
SVG, PNG, WebP - scalable to any size
400k+ Logos
Stocks, ETFs, Crypto, Banks, and more
Where to Use Stock Logos
Trading Platforms
Real-time stock displays with instant logo loading
Portfolio Apps
Visualize holdings with recognizable brand logos
Financial Dashboards
Enhance market data with company branding
News & Research
Illustrate articles with accurate company logos
Frequently Asked Questions
The Jiangsu Yahong Meditech Co., Ltd. (SHA:688176) logo is a trademark of its respective owner. logostream is not affiliated with Jiangsu Yahong Meditech Co., Ltd. (SHA:688176) and provides this logo for identification purposes only. Logo usage is subject to the trademark holder's brand guidelines -- see our Terms of Service for the attribution requirements that apply to the Logo API.
Need Stock Logos for Your Application?
Access 380,000+ company logos via our simple REST API. Perfect for trading platforms, portfolio apps, and financial dashboards.